Literature DB >> 35300082

Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials In Vitro.

Hanan Almolhim1, Sha Ding1, Joshua H Butler2, Emily K Bremers2, Grant J Butschek2, Carla Slebodnick1, Emilio F Merino2, Zaira Rizopoulos3, Maxim Totrov4, Maria B Cassera2, Paul R Carlier1.   

Abstract

The tetrahydro-β-carboline scaffold has proven fertile ground for the discovery of antimalarial agents (e.g., MMV008138 (1) and cipargamin (2)). Similarity searching of a publicly disclosed collection of antimalarial hits for molecules resembling 1 drew our attention to N2-acyl tetrahydro-β-carboline GNF-Pf-5009 ((±)-3b). Compound purchase, "analog by catalog", and independent synthesis of hits indicated the benzofuran-2-yl amide portion was required for in vitro efficacy against P. falciparum. Preparation of pure enantiomers demonstrated the pharmacological superiority of (R)-3b. Synthesis and evaluation of D- and F-ring substitution variants and benzofuran isosteres indicated a clear structure-activity relationship. Ultimately (R)-3b was tested in Plasmodium berghei-infected mice; unfavorable physicochemical properties may be responsible for the lack of oral efficacy.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35300082      PMCID: PMC8919387          DOI: 10.1021/acsmedchemlett.1c00697

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  16 in total

1.  A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis.

Authors:  Wesley Wu; Zachary Herrera; Danny Ebert; Katie Baska; Seok H Cho; Joseph L DeRisi; Ellen Yeh
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Probing the B- & C-rings of the antimalarial tetrahydro-β-carboline MMV008138 for steric and conformational constraints.

Authors:  Sha Ding; Maryam Ghavami; Joshua H Butler; Emilio F Merino; Carla Slebodnick; Maria B Cassera; Paul R Carlier
Journal:  Bioorg Med Chem Lett       Date:  2020-09-06       Impact factor: 2.823

3.  Spiroindolones, a potent compound class for the treatment of malaria.

Authors:  Matthias Rottmann; Case McNamara; Bryan K S Yeung; Marcus C S Lee; Bin Zou; Bruce Russell; Patrick Seitz; David M Plouffe; Neekesh V Dharia; Jocelyn Tan; Steven B Cohen; Kathryn R Spencer; Gonzalo E González-Páez; Suresh B Lakshminarayana; Anne Goh; Rossarin Suwanarusk; Timothy Jegla; Esther K Schmitt; Hans-Peter Beck; Reto Brun; Francois Nosten; Laurent Renia; Veronique Dartois; Thomas H Keller; David A Fidock; Elizabeth A Winzeler; Thierry T Diagana
Journal:  Science       Date:  2010-09-03       Impact factor: 47.728

4.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

Authors:  H Jomaa; J Wiesner; S Sanderbrand; B Altincicek; C Weidemeyer; M Hintz; I Türbachova; M Eberl; J Zeidler; H K Lichtenthaler; D Soldati; E Beck
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

5.  Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.

Authors:  Stephan Meister; David M Plouffe; Kelli L Kuhen; Ghislain M C Bonamy; Tao Wu; S Whitney Barnes; Selina E Bopp; Rachel Borboa; A Taylor Bright; Jianwei Che; Steve Cohen; Neekesh V Dharia; Kerstin Gagaring; Montip Gettayacamin; Perry Gordon; Todd Groessl; Nobutaka Kato; Marcus C S Lee; Case W McNamara; David A Fidock; Advait Nagle; Tae-gyu Nam; Wendy Richmond; Jason Roland; Matthias Rottmann; Bin Zhou; Patrick Froissard; Richard J Glynne; Dominique Mazier; Jetsumon Sattabongkot; Peter G Schultz; Tove Tuntland; John R Walker; Yingyao Zhou; Arnab Chatterjee; Thierry T Diagana; Elizabeth A Winzeler
Journal:  Science       Date:  2011-11-17       Impact factor: 47.728

6.  Weak Brønsted acid-thiourea co-catalysis: enantioselective, catalytic protio-Pictet-Spengler reactions.

Authors:  Rebekka S Klausen; Eric N Jacobsen
Journal:  Org Lett       Date:  2009-02-19       Impact factor: 6.005

7.  Biological Studies and Target Engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and Analogs.

Authors:  Maryam Ghavami; Emilio F Merino; Zhong-Ke Yao; Rubayet Elahi; Morgan E Simpson; Maria L Fernández-Murga; Joshua H Butler; Michael A Casasanta; Priscilla M Krai; Maxim M Totrov; Daniel J Slade; Paul R Carlier; Maria Belen Cassera
Journal:  ACS Infect Dis       Date:  2017-11-07       Impact factor: 5.084

8.  Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.

Authors:  Jessica D Bowman; Emilio F Merino; Carrie F Brooks; Boris Striepen; Paul R Carlier; Maria B Cassera
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

9.  The open access malaria box: a drug discovery catalyst for neglected diseases.

Authors:  Thomas Spangenberg; Jeremy N Burrows; Paul Kowalczyk; Simon McDonald; Timothy N C Wells; Paul Willis
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

10.  Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.

Authors:  James M Murithi; Edward S Owen; Eva S Istvan; Marcus C S Lee; Sabine Ottilie; Kelly Chibale; Daniel E Goldberg; Elizabeth A Winzeler; Manuel Llinás; David A Fidock; Manu Vanaerschot
Journal:  Cell Chem Biol       Date:  2019-12-05       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.